Bern cannabis study rejected for legal reasons
The office did not reject the pilot project outright, saying from a health policy perspective “such projects explore new approaches by society to cannabis”
Tuesday, November 14, 2017
The University of Bern cannot conduct a study on the effects of the regulated sale of cannabis in pharmacies on behalf of the city’s authorities. In a written reply the Federal Office of Public Health says the legal framework does not exist to authorise such a scientific project as “current drugs legislation does not allow the use of cannabis for non-medical reasons”. In May 2017, researchers from the university’s Institute of Social and Preventive Medicine and the Clinical Trials Unit filed a request with the health office for an authorisation to carry out a scientific study on the effects of the regulated sale of cannabis for recreational purposes via pharmacies. It also planned to study the illegal cannabis market in the Swiss capital. (Bundesrat Berset blockiert Cannabis-Politik der Städte)